Fund Companies Rights Offerings Managed Distributions Leveraged Funds IPOs Asset Classes CEF Advisors

My Fund Comparison
Initilizing list...

Tekla Healthcare Investors  as of 10/06/2015

NYSE / HQH Asset Class:  Sector Equity Funds 1 YR Lipper Avg:  -1.13%

Growth of $10K

Avg Annual Total Return %
  10 YR 5 YR 1 YR YTD
Market Return 13.42% 29.09% 10.84% -2.55%
Lipper Pct. Rank 25 19 25 36
NAV Return 12.49% 24.63% 9.10% -0.46%
Lipper Pct. Rank 29 20 27 36
Premium/Discount History

10 YR Avg 5 YR Avg YTD Avg
-7.717% -4.546% 1.590%

NAV $29.58 Market Price $28.91
Net Change -$0.97 Market Change -$1.08
Premium/Discount -2.27%
1 YR NAV Return 9.097%
1 YR NAV Rank 27
12-Mo Yield as of 8/31/2015 Yield Def
Income Only Yield 0.00%
Distribution Yield (Market) 9.46%
Managed Distribution Plan 
Most Recent Income Dividend $0.680
Ex-Div Date 5/22/2015
Most Recent Cap Gain Dividend $0.710
Ex-Div Date 8/26/2015
Dividend Frequency Quarterly
YTD Dividends $1.310
YTD Capital Gains $0.710
Inception Date 4/23/1987
Fund Advisor Tekla Capital Management LLC
Manager & Tenure Team Managed
Phone 800-451-2597
Total Net Assets (mil) as of 8/31/2015 $1,220.4
% Leveraged Assets as of 9/30/2014 --
Portfolio Turnover --
Mgmt Fees 0.960%
Expense Ratio 1.130%
Fund Objective
The Fund seeks long-term capital appreciation by investing primarily in securities of companies in the health services and medical technology (health care) industries ("Health care Companies").
Top Holdings (as of 3/31/2015)
Celgene Corp ORD 9.26%
Gilead Sciences Inc ORD 7.91%
Allergan plc ORD 6.08%
Biogen Inc ORD 5.58%
Regeneron Pharmaceuticals Inc ORD 4.84%
Alexion Pharmaceuticals Inc ORD 4.17%
Biomarin Pharmaceutical Inc ORD 4.10%
Incyte Corp ORD 3.77%
Amgen Inc ORD 3.16%
Vertex Pharmaceuticals Inc ORD 3.11%
Top Sectors (as of 3/31/2015)
Health Care 84.37%
Non Classified Equity 6.63%
Technology 1.97%
Consumer Services 1.24%

Image Map


Aberdeen Closed-End TV

CEF Connect


National Association of
Publicly Traded Partnerships


Seeking Alpha CEF Articles
SySys Logo

Lipper Logo
Powered by a SySys data & content management system.

© Thomson Reuters 2011. All rights reserved. Any copying, republication or redistribution of Lipper, a Thomson Reuters company, content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Lipper, a Thomson Reuters company. Lipper, a Thomson Reuters company shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.